Intra-abdominal mycoses;Intraabdominelle pilzinfektionen

Mycoses, Supplement

Volumn 48, Issue 1, 2005, Pages 22-26

  Boos, C ^a   Kujath, P ^a   Bruch, H P ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Antimycotic chemotherapy; Epidemiology; Monitoring; Peritonitis

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; CASPOFUNGIN; FLUCYTOSINE; VORICONAZOLE;

ABDOMINAL INFECTION; ABDOMINAL SURGERY; CONFERENCE PAPER; EARLY DIAGNOSIS; ERADICATION THERAPY; HISTOPATHOLOGY; HUMAN; IATROGENIC DISEASE; INCIDENCE; LETHALITY; MYCOSIS; PRIORITY JOURNAL; RISK FACTOR; SYSTEMIC DISEASE; VALIDATION PROCESS;

ANTIFUNGAL AGENTS; ASPERGILLOSIS; ASPERGILLUS; CANDIDA ALBICANS; CANDIDIASIS; HUMANS; MYCOSES; PERITONITIS; RISK FACTORS;

EID: 17844369985     PISSN: 09437312     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (32)

1. Groll AH, Shah PM, Mentzel C et al. Trends in the postmortem epidemiology of invasive fungal infections at a university hospital. J Infect 1996; 33: 23-32.
2. Vincent JL, Anaissie E, Bruining H et al. Epidemiology, diagnosis and treatment of systemic Candida infection in surgical patients under intensive care. Intensive Care Med 1998; 24: 206-16.
3. Vincent JL, Bihari DJ, Suter PM et al. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA 1995; 274: 639-44.
4. Jarvis WR. Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin Infect Dis 1995; 20: 1526-30.
5. Dean DA, Burchard KW. Fungal infection in surgical patients. Am J Surg 1996; 171: 374-82.
6. Nolla-Salas J, Sitges-Serra A et al. Candidemia in non-neutropenic critically ill patients: analysis of prognostic factors and assessment of systemic antifungal therapy. Study Group of Fungal Infection in the ICU. Intensive Care Med 1997; 23: 23-30.
7. Anaissie EJ, Solomkin FS. Fungal Infection. Scientific American 1994. Infection Chapter 10.
8. Dean DA, Burchard KW. Surgical perspective on invasive Candida infections. World J Surg 1998; 22: 127-34.
9. Edwards Jr JE, Bodey GP et al. International conference for the development of a consensus on the management and prevention of severe candidal infections. Clin Infect Dis 1997; 25: 43-59.
10. Uzun O, Ascioglu S et al. Risk factors and predictors of outcome in patients with cancer and breakthrough candidemia. Clin Infect Dis 2001; 32: 1713-7.
11. Boey J, Wong J et al. Bacteria and septic complications in patients with perforated duodenal ulcers. Am J Surg 1982; 143: 635.
12. Brooks JR, Smith HF, Pease FB. Bacteriology of the stomach immediately following vagotomy. Ann Surg 1974; 179: 859-62.
13. Kujath P, Lerch K et al. Fluconazol monitoring in Candida peritonitis based on histological control. Mycoses 1990; 33: 441-8.
14. Knothe H, Dette GA, Shah PM. Einfluß parenteraler Cephalosporine auf die gastro-intestinale Mikroflora. Infection 1985; 13: 129.
15. Höchter W, Wagner N, Hemmer F et al. Pilzbesiedlung gastroduodenaler Ulcera. Dtsch med Wschr 1982; 107: 845-8.
16. Oehlert W, Preuss B. Häufigkeit und Bedeutung der Soormykose im Biopsie-Material des Ulcus ventriculi. Dtsch med Wschr 1980; 105: 1773-6.
17. Kujath P, Markert U, Boos C. Die Bedeutung von Candida albicans beim komplizierten Ulcus ventriculi et duodeni. Langenbeck Arch Chir 1994; (Suppl): 417-9.
18. Edwards JE. Invasive Candida infections, evolution of a fungal pathogen. N Eng J Med 1991; 324: 1060-1.
19. Sherlock DJ, Benjamin JS. Clinical aspects of intra-abdominal infection. In: Gorbach SL (ed.), Intra-abdominal Infections: the Role of Piperacillin/tazobactam. Chicago: PharmaLibri, 1994: 51-63.
20. Bayer AS, Blumenkrantz HJ et al. Candida peritonitis; report of 22 cases and review of the English literature. Am J Med 1976; 61: 832.
21. Eisenberg ES, Leviten L et al. Fungal peritonitis in patients receiving peritoneal dialysis: experience with 11 patients and review of the literature. Rev Infect Dis 1986; 8: 309.
22. Sobel JD. Candida infections in the intensive care unit. Critical Care Clinics 1988; 4: 325-44.
23. Corbella X, Sirvent JM et al. Fluconazole treatment without catheter remnoval in Candida albicans peritonitis complicating peritoneal dialysis. Am J Med 1991: 90: 227.
24. Levine L, Bernard DB et al. Fungal peritonitis complicating continuous ambulatory peritoneal dialysis: successful treatment with fluconazole, a new orally active antifungal agent. Ann J Mod 1989; 86: 825-7.
25. Kern E, Klaue P et al. Programmierte Peritoneal-Lavage bei diffuser Peritonitis. Chirurg 1983; 54: 306-9.
26. Kujath P, Kochendörfer P et al. Die Pilzperitonitis. Chirurg 1990; 61: 900-5.
27. Kujath P. Technik und Wertung der verschiedenen Spülmethoden bei der Peritonitis. Akt Chir 1991; 21: 216-21.
28. Guerin JM, Loeve G et al. Péritonites postoperatoires à Candida albicans. La Nouvelle Presse Medicale 1981; 10: 2983-5.
29. Gianotta E, Alexander FW et al. Translocation of Candida albicans is related to the blood flow of individual intestinal villi. Circ Shock 1993; 40: 250.
30. Philipps P, Dowd A et al Nonvalue of antigen detection immunoassays for diagnosis of candidemia. J Clin Microbid 1990; 28: 2320-6.
31. Rex JH, Bennett JE et al. A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute. N Engl J Med 1994; 331: 1325-30.
32. Kujath P, Lerch K et al. Comparative study of the efficacy of fluconazole versus amphotericin B/flucytosine in surgical patients with systemic mycoses. Infection 1993; 21: 376-82.